| scholarly article | Q13442814 |
| P2093 | author name string | John C Elfar | |
| M A Hassan Talukder | |||
| John P Hegarty | |||
| Prem Kumar Govindappa | |||
| Anagha A Gurjar | |||
| P2860 | cites work | The Regulation of NF-κB Subunits by Phosphorylation | Q26752951 |
| The Role of Current Techniques and Concepts in Peripheral Nerve Repair | Q26767350 | ||
| Erythropoietin: new directions for the nervous system | Q26828425 | ||
| The pleiotropic effects of erythropoietin in infection and inflammation | Q26864149 | ||
| Peripheral nerve reconstruction after injury: a review of clinical and experimental therapies | Q27693253 | ||
| 1,026 experimental treatments in acute stroke | Q29615509 | ||
| Modified forelimb grip strength test detects aging-associated physiological decline in skeletal muscle function in male mice | Q30837885 | ||
| Fast skeletal muscle troponin activator tirasemtiv increases muscle function and performance in the B6SJL-SOD1G93A ALS mouse model | Q33578284 | ||
| Effect of hypoxia-inducible factor-1/vascular endothelial growth factor signaling pathway on spinal cord injury in rats | Q33598653 | ||
| A simplified up-down method (SUDO) for measuring mechanical nociception in rodents using von Frey filaments | Q33609346 | ||
| Traumatic injury to peripheral nerves. | Q33936632 | ||
| Erythropoietin ameliorates rat experimental autoimmune neuritis by inducing transforming growth factor-β in macrophages | Q34063671 | ||
| Pathophysiology of peripheral nerve injury: a brief review | Q34324206 | ||
| Nerve physiology: mechanisms of injury and recovery | Q34360451 | ||
| The role of erythropoietin in central and peripheral nerve injury | Q34648857 | ||
| Evaluation and management of peripheral nerve injury | Q34778872 | ||
| Epoetin alfa. Clinical evolution of a pleiotropic cytokine | Q35652564 | ||
| Erythropoietin accelerates functional recovery after peripheral nerve injury | Q35750138 | ||
| Erythropoietin as an antiapoptotic, tissue-protective cytokine. | Q35831214 | ||
| Hypoxia-induced angiogenesis: good and evil | Q36137705 | ||
| Erythropoietin update 2011 | Q36516298 | ||
| Antioxidative effects of erythropoietin | Q36974225 | ||
| The non-haematopoietic biological effects of erythropoietin | Q37103957 | ||
| Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response | Q37328549 | ||
| The NF-kappaB family of transcription factors and its regulation | Q37672294 | ||
| Non-surgical therapies for peripheral nerve injury | Q37856566 | ||
| Erythropoietin: a hormone with multiple functions | Q37862940 | ||
| Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research | Q37880995 | ||
| Erythropoietin, erythropoiesis and beyond | Q37904170 | ||
| Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF. | Q38582583 | ||
| The physiology of neural injury and regeneration: The role of neurotrophic factors | Q39706476 | ||
| Neuroprotective potential of erythropoietin and darbepoetin alfa in an experimental model of sciatic nerve injury. Laboratory investigation | Q40145007 | ||
| Erythropoietin attenuates renal and pulmonary injury in polymicrobial induced-sepsis through EPO-R, VEGF and VEGF-R2 modulation. | Q40595880 | ||
| Erythropoietin Enhanced Recovery After Traumatic Nerve Injury: Myelination and Localized Effects | Q41648362 | ||
| Measuring changes in tactile sensitivity in the hind paw of mice using an electronic von Frey apparatus. | Q42151246 | ||
| Localized and sustained delivery of erythropoietin from PLGA microspheres promotes functional recovery and nerve regeneration in peripheral nerve injury | Q42176347 | ||
| Erythropoietin: a multimodal neuroprotective agent | Q42922791 | ||
| Erythropoietin and blood doping | Q43160653 | ||
| Spinal D-amino acid oxidase contributes to neuropathic pain in rats | Q43261398 | ||
| Recombinant human erythropoietin attenuates spinal neuroimmune activation of neuropathic pain in rats. | Q43506018 | ||
| Specific Inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. | Q44016790 | ||
| Erythropoietin reduces Schwann cell TNF-alpha, Wallerian degeneration and pain-related behaviors after peripheral nerve injury | Q45106915 | ||
| Effects of recombinant human erythropoietin on neuropathic pain and cerebral expressions of cytokines and nuclear factor-kappa B. | Q47804482 | ||
| Increased activation of nuclear factor kappa B in rat lumbar dorsal root ganglion neurons following partial sciatic nerve injuries | Q47836336 | ||
| Erythropoietin is a hypoxia inducible factor-induced protective molecule in experimental autoimmune neuritis. | Q51056429 | ||
| Erythropoietin accelerates functional recovery after moderate sciatic nerve crush injury. | Q51149238 | ||
| Measurement of Reactive Oxygen Species (ROS) and Mitochondrial ROS in AMPK Knockout Mice Blood Vessels. | Q52685560 | ||
| Erythropoietin promotes functional recovery and enhances nerve regeneration after peripheral nerve injury in rats | Q82347562 | ||
| Peripheral nerve injury and myelination: Potential therapeutic strategies | Q90683634 | ||
| Erythropoietin as a Neuroprotective Molecule: An Overview of Its Therapeutic Potential in Neurodegenerative Diseases | Q92877211 | ||
| Erythropoietin reduces nerve demyelination, neuropathic pain behavior and microglial MAPKs activation through erythropoietin receptors on Schwann cells in a rat model of peripheral neuropathy | Q92995199 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P304 | page(s) | 106330 | |
| P577 | publication date | 2020-03-03 | |
| P1433 | published in | International Immunopharmacology | Q15751306 |
| P1476 | title | An effective erythropoietin dose regimen protects against severe nerve injury-induced pathophysiological changes with improved neural gene expression and enhances functional recovery | |
| P478 | volume | 82 |
Search more.